MedTrace Logo

Identification of Protective and Worsening Steatohepatitis (NASH) Factors

NCT00914446 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2009-06-05

No results posted yet for this study

Summary

The main aim of this work will be to identify a profile of gene expression by microarray in the liver which might allow to differentiate obese subjects having a normal liver from those with steatohepatitis or steatosis.

Conditions

  • Morbid Obesity
  • Steatohepatitis
  • Steatosis

Interventions

PROCEDURE

hepatic biopsies

hepatic biopsies

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Nice

    lead OTHER

Principal Investigators

  • ALBERT TRAN, Ph D · Centre Hospitalier Universitaire de Nice

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2009-12-31
Completion
2010-04-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00914446 on ClinicalTrials.gov